OCT 30, 2014 12:00 PM PDT

Breast-Predict: Leveraging the Power of Systems Medicine Towards Personalized Cancer Therapy

Speaker

Abstract

Although the incidence of breast cancer is steadily increasing, mortality rates are decreasing. This means that the majority of women with breast cancer now survive, making it even more important to tailor therapy appropriately, reducing toxicity and long-term side-effects. Some patients still succumb despite early intervention, and improved stratification approaches and more diverse treatment options are required.

This presentation will outline the benefits of a collaborative, inter-disciplinary approach to address key challenges in breast cancer, in particular in relation to the personalisation of therapy. A working case model will be provided of a virtual Collaborative Cancer Research Centre, BREAST-PREDICT (www.breastpredict.com), which tackles clinical needs with respect to the development of more individualised therapies for breast cancer. The BREAST-PREDICT model incorporates the diverse skill sets of several disciplines, including biological, mathematical, computational, pharmaco-epidemiological and systems medicine approaches, in order to determine how to treat individual breast cancer patients according to the particular characteristics of their own cancer.

BREAST-PREDICT is consolidating existing breast cancer biobank and data resources, and making these available for research projects. Pharmaco-epidemiology approaches are being employed to determine the effects of previous drug exposures on outcome, and multi-omic analyses are being performed on longitudinal samples from primary and metastatic tumours, in order to map the molecular evolution of breast cancer. The group is also leveraging these resources in order to identify new therapeutic targets and combinatorial treatment strategies for specific subtypes, and to develop new tools for improved prediction of patient outcome and response to treatment. The presentation will outline the benefit of this approach and how it can be used to fast-track progress towards personalised therapy in breast cancer.


Show Resources
You May Also Like
FEB 15, 2023 7:00 AM PST
FEB 15, 2023 7:00 AM PST
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
NOV 07, 2022 9:00 PM PST
C.E. CREDITS
NOV 07, 2022 9:00 PM PST
Date: November 8, 2022 Time: 1:00pm (SGT), 12:00pm (EST), 6:00am (CET) Antibodies are vital tools in many of the laboratory techniques that are used...
OCT 30, 2014 12:00 PM PDT

Breast-Predict: Leveraging the Power of Systems Medicine Towards Personalized Cancer Therapy



Show Resources
Loading Comments...
Show Resources
Attendees